Skip to main content

This is a preview of improvements coming to the PMC website in October 2024. Learn more

Return to current site
PMC
Logo of The Journal of Clinical Investigation Link to view articles on publisher site
. 1997 Oct 1;100(7):1797–1803. doi: 10.1172/JCI119707

Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells.

N Franchimont 1, S Rydziel 1, E Canalis 1
PMCID: PMC508365  PMID: 9312180

Abstract

Interleukin 6 (IL-6), a cytokine produced by skeletal cells, stimulates osteoclast recruitment. The IL-6 soluble receptor (sIL-6R) increases IL-6 activity, and IL-6 and sIL-6R levels are increased in conditions of increased bone resorption. We examined the production of IL-6 by primary rat osteoblasts (Ob cells) cultured in the presence of IL-6 and sIL-6R. IL-6 alone did not induce IL-6 transcripts, but IL-6 was stimulatory in the presence of sIL-6R. Furthermore, sIL-6R by itself increased IL-6 transcripts. Cycloheximide superinduced IL-6 transcripts and did not prevent the effect of IL-6 and sIL-6R. IL-6 in the presence of sIL-6R stimulated IL-6 rates of transcription and the activity of IL-6 promoter fragments in transiently transfected Ob cells. 5' deletions of the IL-6 promoter and targeted mutations of the multiple response element (MRE)/cAMP responsive element (CRE), the nuclear factor for IL-6 (NF-IL-6), and the nuclear factor-kappaB (NF-kappaB) binding sites indicated that NF-IL-6 and NF-kappaB, in combination with MRE/CRE, binding sites are required for the induction of the IL-6 promoter by IL-6. In conclusion, IL-6 induces its own synthesis in osteoblasts by transcriptional mechanisms. This positive feedback may be important in conditions of increased bone resorption.

Full Text

The Full Text of this article is available as a PDF (277.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Isshiki H., Nakajima T., Kinoshita S., Nishio Y., Hashimoto S., Natsuka S., Kishimoto T. A nuclear factor for the IL-6 gene (NF-IL6). Chem Immunol. 1992;51:299–322. [PubMed] [Google Scholar]
  2. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990 Jun;9(6):1897–1906. doi: 10.1002/j.1460-2075.1990.tb08316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baffet G., Braciak T. A., Fletcher R. G., Gauldie J., Fey G. H., Northemann W. Autocrine activity of interleukin 6 secreted by hepatocarcinoma cell lines. Mol Biol Med. 1991 Feb;8(1):141–156. [PubMed] [Google Scholar]
  4. Bataille R., Chappard D., Klein B. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res. 1992;21(4):283–287. doi: 10.1007/BF02591662. [DOI] [PubMed] [Google Scholar]
  5. Bellido T., Stahl N., Farruggella T. J., Borba V., Yancopoulos G. D., Manolagas S. C. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest. 1996 Jan 15;97(2):431–437. doi: 10.1172/JCI118432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Centrella M., McCarthy T. L., Canalis E. Platelet-derived growth factor enhances deoxyribonucleic acid and collagen synthesis in osteoblast-enriched cultures from fetal rat parietal bone. Endocrinology. 1989 Jul;125(1):13–19. doi: 10.1210/endo-125-1-13. [DOI] [PubMed] [Google Scholar]
  7. Centrella M., McCarthy T. L., Kusmik W. F., Canalis E. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures from fetal rat bone. J Cell Physiol. 1991 Jun;147(3):420–426. doi: 10.1002/jcp.1041470306. [DOI] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Dendorfer U., Oettgen P., Libermann T. A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol. 1994 Jul;14(7):4443–4454. doi: 10.1128/mcb.14.7.4443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  11. Feyen J. H., Elford P., Di Padova F. E., Trechsel U. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 1989 Aug;4(4):633–638. doi: 10.1002/jbmr.5650040422. [DOI] [PubMed] [Google Scholar]
  12. Frieling J. T., Sauerwein R. W., Wijdenes J., Hendriks T., van der Linden C. J. Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine. 1994 Jul;6(4):376–381. doi: 10.1016/1043-4666(94)90061-2. [DOI] [PubMed] [Google Scholar]
  13. Gaillard J. P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., Maruo N., Taga T., Kishimoto T., Klein B. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol. 1993 Apr;23(4):820–824. doi: 10.1002/eji.1830230408. [DOI] [PubMed] [Google Scholar]
  14. Godfrey K. Statistics in practice. Comparing the means of several groups. N Engl J Med. 1985 Dec 5;313(23):1450–1456. doi: 10.1056/NEJM198512053132305. [DOI] [PubMed] [Google Scholar]
  15. Greenberg M. E., Ziff E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984 Oct 4;311(5985):433–438. doi: 10.1038/311433a0. [DOI] [PubMed] [Google Scholar]
  16. Greenfield E. M., Shaw S. M., Gornik S. A., Banks M. A. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest. 1995 Sep;96(3):1238–1244. doi: 10.1172/JCI118157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heinrich P. C., Graeve L., Rose-John S., Schneider-Mergener J., Dittrich E., Erren A., Gerhartz C., Hemann U., Lütticken C., Wegenka U. Membrane-bound and soluble interleukin-6 receptor: studies on structure, regulation of expression, and signal transduction. Ann N Y Acad Sci. 1995 Jul 21;762:222–237. doi: 10.1111/j.1749-6632.1995.tb32328.x. [DOI] [PubMed] [Google Scholar]
  18. Helle M., Brakenhoff J. P., De Groot E. R., Aarden L. A. Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol. 1988 Jun;18(6):957–959. doi: 10.1002/eji.1830180619. [DOI] [PubMed] [Google Scholar]
  19. Jilka R. L., Hangoc G., Girasole G., Passeri G., Williams D. C., Abrams J. S., Boyce B., Broxmeyer H., Manolagas S. C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992 Jul 3;257(5066):88–91. doi: 10.1126/science.1621100. [DOI] [PubMed] [Google Scholar]
  20. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988 Mar 3;332(6159):83–85. doi: 10.1038/332083a0. [DOI] [PubMed] [Google Scholar]
  21. Klein B., Zhang X. G., Lu Z. Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood. 1995 Feb 15;85(4):863–872. [PubMed] [Google Scholar]
  22. Kurihara N., Civin C., Roodman G. D. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res. 1991 Mar;6(3):257–261. doi: 10.1002/jbmr.5650060307. [DOI] [PubMed] [Google Scholar]
  23. Littlewood A. J., Russell J., Harvey G. R., Hughes D. E., Russell R. G., Gowen M. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology. 1991 Sep;129(3):1513–1520. doi: 10.1210/endo-129-3-1513. [DOI] [PubMed] [Google Scholar]
  24. Lust J. A., Donovan K. A., Kline M. P., Greipp P. R., Kyle R. A., Maihle N. J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 1992 Mar;4(2):96–100. doi: 10.1016/1043-4666(92)90043-q. [DOI] [PubMed] [Google Scholar]
  25. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10193–10197. doi: 10.1073/pnas.90.21.10193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McCarthy T. L., Centrella M., Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res. 1988 Aug;3(4):401–408. doi: 10.1002/jbmr.5650030406. [DOI] [PubMed] [Google Scholar]
  27. Müllberg J., Schooltink H., Stoyan T., Günther M., Graeve L., Buse G., Mackiewicz A., Heinrich P. C., Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol. 1993 Feb;23(2):473–480. doi: 10.1002/eji.1830230226. [DOI] [PubMed] [Google Scholar]
  28. Northemann W., Braciak T. A., Hattori M., Lee F., Fey G. H. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem. 1989 Sep 25;264(27):16072–16082. [PubMed] [Google Scholar]
  29. Pash J. M., Delany A. M., Adamo M. L., Roberts C. T., Jr, LeRoith D., Canalis E. Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells. Endocrinology. 1995 Jan;136(1):33–38. doi: 10.1210/endo.136.1.7828549. [DOI] [PubMed] [Google Scholar]
  30. Roodman G. D. Interleukin-6: an osteotropic factor? J Bone Miner Res. 1992 May;7(5):475–478. doi: 10.1002/jbmr.5650070502. [DOI] [PubMed] [Google Scholar]
  31. Rose-John S., Ehlers M., Grötzinger J., Müllberg J. The soluble interleukin-6 receptor. Ann N Y Acad Sci. 1995 Jul 21;762:207–221. [PubMed] [Google Scholar]
  32. Sehgal P. B. Regulation of IL6 gene expression. Res Immunol. 1992 Sep;143(7):724–734. doi: 10.1016/0923-2494(92)80011-9. [DOI] [PubMed] [Google Scholar]
  33. Stoyan T., Michaelis U., Schooltink H., Van Dam M., Rudolph R., Heinrich P. C., Rose-John S. Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur J Biochem. 1993 Aug 15;216(1):239–245. doi: 10.1111/j.1432-1033.1993.tb18138.x. [DOI] [PubMed] [Google Scholar]
  34. Suzuki H., Yasukawa K., Saito T., Narazaki M., Hasegawa A., Taga T., Kishimoto T. Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur J Immunol. 1993 May;23(5):1078–1082. doi: 10.1002/eji.1830230515. [DOI] [PubMed] [Google Scholar]
  35. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989 Aug 11;58(3):573–581. doi: 10.1016/0092-8674(89)90438-8. [DOI] [PubMed] [Google Scholar]
  36. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Yamada Y., Koishihara Y., Ohsugi Y., Kumaki K., Taga T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11924–11928. doi: 10.1073/pnas.90.24.11924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Walther Z., May L. T., Sehgal P. B. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines. J Immunol. 1988 Feb 1;140(3):974–977. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES

-